---
authors:
- ReactomeTeam
description: 'Because of their hydrophobicity, lipids are found in the extracellular
  spaces of the human body primarily in the form of lipoprotein complexes. <b>Chylomicrons</b>
  form in the small intestine and transport dietary lipids to other tissues in the
  body. <b>Very low density lipoproteins (VLDL)</b> form in the liver and transport
  triacylglycerol synthesized there to other tissues of the body. As they circulate,
  VLDL are acted on by lipoprotein lipases on the endothelial surfaces of blood vessels,
  liberating fatty acids and glycerol to be taken up by tissues and converting the
  VLDL first to <b>intermediate density lipoproteins (IDL)</b> and then to <b>low
  density lipoproteins (LDL)</b>. IDL and LDL are cleared from the circulation via
  a specific cell surface receptor, found in the body primarily on the surfaces of
  liver cells. <b>High density lipoprotein (HDL)</b> particles, initially formed primarily
  by the liver, shuttle several kinds of lipids between tissues and other lipoproteins.
  Notably, they are responsible for the so-called reverse transport of cholesterol
  from peripheral tissues to LDL for return to the liver.<p>Three aspects of lipoprotein
  function are currently annotated in Reactome: <b>chylomicron-mediated lipid transport</b>,
  <b>LDL endocytosis and degradation</b>, and <b>HDL-mediated lipid transport</b>,
  each divided into assembly, remodeling, and clearance subpathways.  View original
  pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=174824 Reactome].'
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4129
- /instance/WP4129
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4129.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: 'Because of their hydrophobicity, lipids are found in the extracellular
    spaces of the human body primarily in the form of lipoprotein complexes. <b>Chylomicrons</b>
    form in the small intestine and transport dietary lipids to other tissues in the
    body. <b>Very low density lipoproteins (VLDL)</b> form in the liver and transport
    triacylglycerol synthesized there to other tissues of the body. As they circulate,
    VLDL are acted on by lipoprotein lipases on the endothelial surfaces of blood
    vessels, liberating fatty acids and glycerol to be taken up by tissues and converting
    the VLDL first to <b>intermediate density lipoproteins (IDL)</b> and then to <b>low
    density lipoproteins (LDL)</b>. IDL and LDL are cleared from the circulation via
    a specific cell surface receptor, found in the body primarily on the surfaces
    of liver cells. <b>High density lipoprotein (HDL)</b> particles, initially formed
    primarily by the liver, shuttle several kinds of lipids between tissues and other
    lipoproteins. Notably, they are responsible for the so-called reverse transport
    of cholesterol from peripheral tissues to LDL for return to the liver.<p>Three
    aspects of lipoprotein function are currently annotated in Reactome: <b>chylomicron-mediated
    lipid transport</b>, <b>LDL endocytosis and degradation</b>, and <b>HDL-mediated
    lipid transport</b>, each divided into assembly, remodeling, and clearance subpathways.  View
    original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=174824 Reactome].'
  keywords:
  - 'APOA5 '
  - FURIN,PCSK6
  - 'APOE '
  - LIPC dimer:heparin
  - 4xPALM-C-ABCA1
  - 'Heparins '
  - NCEH1
  - PKA catalytic
  - 'Zn2+ '
  - LCFAs
  - subunit
  - 'CLTC '
  - PCSK9:LDLR:Clathrin:AP2
  - 'PLTP-2 '
  - PL
  - remnant:apoE:LDLR
  - 'NR1H3 '
  - 4xPALM-C-p-2S-ABCA1
  - SOAT1,2
  - 'PRKACA '
  - 'A2M '
  - APOC4
  - 'TAG '
  - tetramer
  - apoA-I:CUBN:AMN
  - 'PCSK9 '
  - LPL dimer
  - HSPG:LPL dimer
  - tetramer:APOA1
  - APOA4,APOA5,APOC2,CIDEC,FGF21
  - 'FGF21 '
  - ALB
  - pre-beta HDL
  - ADP
  - APOA4
  - 'APOA1(25-267) '
  - 'HSPG '
  - 'VLDLR '
  - 'LPA '
  - 'SOAT1 '
  - ANGPTL3:ANGPTL8
  - 'GPIHBP1 '
  - ABCA1 tetramer
  - FA
  - FAs
  - 'APOA1(25-266) '
  - ANGPTL4
  - 'LSR '
  - APOB(28-4563)
  - CREB3L3(?-461)
  - phosphatidylcholines
  - ester complex
  - HDL
  - 'APOA4 '
  - 'NR1H2 '
  - ABCG1 dimer
  - acyl-CoA
  - A2M tetramer
  - 'LMF2 '
  - complex
  - LIPC dimer:LMF1,2
  - PCSK9
  - 'PCSK6 '
  - albumin:2-lysophosphatidylcholine complex
  - HDL:apoC-II:apoC-III:apoE
  - Clathrin:AP-2
  - torcetrapib
  - 'PRKACB '
  - LCAT:discoidal HDL
  - APOBR dimer:VLDL
  - VLDL
  - 1-acyl LPC
  - Pi
  - HDL:apoA-I:apoA-II:apoA-IV:apoC-II:apoC-III
  - NPC1
  - '1-acyl LPC '
  - 'LCAT '
  - 'AP2M1 '
  - 'APOB(28-4563) '
  - '4xPALM-C-ABCA1 '
  - HDL:torcetrapib
  - CREB3L3(1-?)
  - 'MBTPS1 '
  - APOC2
  - 'torcetrapib '
  - 'PL '
  - HDL:triacylglycerol
  - MTP:PDI:lipid
  - 'NPC2 '
  - DAGs
  - CREB3L3
  - 'MBTPS2 '
  - 'ABCA1 '
  - LDL:LDLR complex
  - NPC2:CHOL
  - Heparins
  - 'CUBN '
  - CETP:spherical
  - NPC1:CHOL
  - 'AP2S1 '
  - CHEST
  - CETP:cholesterol
  - LSR trimer:LDL
  - APOB(28-2179)
  - LCAT
  - 'cholesterol '
  - discoidal
  - chylomicron
  - LSR trimer
  - SAR1B
  - CUBN:AMN
  - LDLRAP1
  - 'ALB '
  - 'BMP1-3 '
  - LPL
  - 'LPL '
  - GPIHBP1
  - LDLR
  - 'MTTP '
  - TAGs
  - LCAT:spherical HDL
  - 'HDLBP '
  - 'ANGPTL3 '
  - LSR trimer:VLDL
  - 'CHOL '
  - cholesterol esters
  - 'AP2A2(1-939) '
  - VLDL (-APOC1,C4)
  - APOE
  - NR1H2,NR1H3
  - PLTP
  - APOC1
  - ATP
  - APOA2(24-100)
  - remnant:apoE
  - 'APOC2 gene '
  - PCSK9:LDLR
  - HDLBP:HDL
  - ApoB-48:TG:PL
  - HSPG
  - 'APOA5 gene '
  - LIPA
  - 'APOBR '
  - CHOL
  - CES3
  - Ub-K839-VLDLR
  - LIPG dimer
  - 'ANGPTL8 '
  - SCARB1-2
  - pre-VLDL
  - 'LMF1 '
  - 'ABCG1 '
  - APOA4,APOA5,APOC2,CIDEC,FGF21 genes
  - HDLBP
  - MBTPS1,2
  - 'FURIN '
  - 'NPC1 '
  - 'PRKACG '
  - nascent chylomicron
  - spherical
  - ZDHHC8
  - 'P4HB '
  - GPIHBP1:HSPG:LPL
  - LPA
  - dimer
  - chylomicron remnant
  - 'TAGs '
  - 'CHEST '
  - 'SCARB1-2 '
  - 'CETP '
  - 'LIPG '
  - 'LDLR '
  - 'AP2B1 '
  - CoA-SH
  - LIPC dimer
  - APOBR dimer
  - '4xPALM-C-p-2S-ABCA1 '
  - ANGPTL3
  - 'AP2A1 '
  - 'cholesterol esters '
  - 'PLTP-1 '
  - MYLIP dimer
  - 'AMN '
  - APOA5
  - LCFA(-)
  - 'APOA2(24-100) '
  - BMP1-3:Zn2+
  - TG-depleted
  - 'CIDEC gene '
  - VLDL:VLDLR
  - ANGPTL8
  - APOF
  - 'LIPC '
  - 'MYLIP '
  - LIPC
  - Clathrin:AP2 complex
  - 'APOC1 '
  - H2O
  - spherical HDL:SR-BI
  - LDL:cholesterol
  - 'APOC4 '
  - VLDL:PCSK9
  - VLDLR
  - 'CIDEC '
  - NPC2
  - APOA1(25-266)
  - HDL:cholesterol
  - TAG
  - PCSK5
  - discoidal HDL
  - 'APOA4 gene '
  - 'APOC2 '
  - LDL
  - 'FGF21 gene '
  - APOC3
  - APOA1(25-267)
  - APOA1(19-266)
  - spherical HDL
  - LMF1,2
  - Lp(a)
  - 'CLTA '
  - 'APOC3 '
  - CETP:triacylglycerol
  - enlarged spherical
  - 'SOAT2 '
  - LIPA-degraded LDL
  - 'APOB(28-2179) '
  - PALM-CoA
  - VLDL:PCSK9:Clathrin:AP2
  license: CC0
  name: Plasma lipoprotein assembly, remodeling, and clearance
seo: CreativeWork
title: Plasma lipoprotein assembly, remodeling, and clearance
wpid: WP4129
---